Thymosin Beta-4 fragment is a peptide studied in tissue repair, immune, and recovery research. At telos rx, the fragment known as TB-500 is offered only as part of the BPC-157 + TB-500 stack, never on its own, and only after a licensed provider reviews your online intake.
What Is the Thymosin Beta-4 Fragment?
Thymosin Beta-4 (TB-4) is a 43-amino-acid peptide naturally present in human tissue. The fragment forms are studied in preclinical research for tissue repair pathways.
Thymosin Beta-4 fragments are not FDA-approved drugs. They are available through compounding pharmacies under valid prescription.
Common Discussion Points
Patients often raise Thymosin Beta-4 during evaluations for:
- Soft tissue recovery research interest
- Connective tissue support discussions
- Cellular migration research
- Recovery research applications
A licensed provider determines clinical appropriateness individually.
Regulatory Context After the July 2026 PCAC Meeting
In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding TB-500, the synthetic thymosin beta-4 fragment, to the list of substances that can be used in compounding, a non-binding step. On October 28, 2026, HHS announced a temporary enforcement discretion policy that covers single-ingredient subcutaneous or intramuscular TB-500 compounded by state-licensed pharmacies with a valid prescription, under strict sourcing, testing and reporting conditions (Federal Register notice). It is not FDA approval, it applies only while FDA decides through rulemaking, and HHS can revisit it. Patients interested in compounded access should consult a licensed provider.
How TelosRX Handles Thymosin Beta-4 Fragment
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner. telos rx does not offer TB-500 on its own; it is prescribed only within the BPC-157 + TB-500 stack.
- Step 1: Complete an asynchronous telehealth intake for the BPC-157 + TB-500 stack.
- Step 2: Licensed provider review.
- Step 3: Prescription issued if clinically appropriate.
- Step 4: Compounded preparation ships discreetly to your door.
Want a licensed provider to review whether a compounded recovery peptide is appropriate for you? A short online visit is the place to start.
See the BPC-157 + TB-500 stack
Important Compliance Information
Thymosin Beta-4 fragment is not FDA-approved. Compounded preparations are prepared under federal compounding regulations.
Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards.
Start your private evaluation for the BPC-157 + TB-500 stack.